Product/Composition:- | Furosemide tablets |
---|---|
Strength:- | 20 mg, 40 mg, and 80 mg tablets |
Form:- | Tablet |
Reference Brands:- | Lasix(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Furosemide is a loop diuretic that inhibits the sodium-potassium-chloride co-transporter in the kidneys, leading to increased urine production. It effectively reduces fluid retention, edema, and blood pressure. Benefits include rapid symptom relief in heart failure, pulmonary edema, and hypertension, supporting cardiovascular health and overall fluid balance.
Furosemide tablets, marketed as Lasix, are approved in the US by the FDA and in the EU via EMA for edema, heart failure, and hypertension management. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical trial and quality data, while the EMA ensures regional safety and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring adherence to regional regulations supports timely approval, safe medication use, and global availability of furosemide tablets, promoting effective fluid management and cardiovascular health worldwide.